How much do I give? Reevaluation of insulin dosing estimation formulas using continuous glucose monitoring

Endocrine Practice

Volumn 16, Issue 3, 2010, Pages 428-432

  King, Allen B ^a  

^a Diabetes Care Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; INSULIN;

ADULT; AGED; ARTICLE; BLOOD GLUCOSE MONITORING; BOLUS INJECTION; CONTINUOUS GLUCOSE MONITORING; DIABETIC PATIENT; DOSE CALCULATION; DRUG DOSE TITRATION; DRUG FORMULATION; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; HYPERGLYCEMIA; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN PUMP; MAJOR CLINICAL STUDY; MALE; RECOMMENDED DRUG DOSE; BLOOD; CARBOHYDRATE DIET; DRUG EFFECT; METHODOLOGY; MIDDLE AGED;

ADULT; AGED; BLOOD GLUCOSE; BLOOD GLUCOSE SELF-MONITORING; DIABETES MELLITUS, TYPE 1; DIETARY CARBOHYDRATES; FEMALE; HUMANS; INSULIN; MALE; MIDDLE AGED; YOUNG ADULT;

EID: 77956622288     PISSN: 1530891X     EISSN: None     Source Type: Journal    
DOI: 10.4158/EP09308.OR     Document Type: Article

References (11)

1. Bliss M. The Discovery of Insulin. Chicago, IL: The University of Chicago Press, 1984: 112-113.
2. Davidson PC, Hebblewhite HR, Steed RD, Bode BW. Analysis of guidelines for basal-bolus insulin dosing: Basal insulin, correction factor, and carbohydrate-to-insulin ratio. Endocr Pract. 2008;14:1095-1101.
3. Bode B. Insulin Pump Therapy. In: Lebovitz HE, ed. Therapy for Diabetes Mellitus and Related Disorders. 4th ed. Alexandria, VA: American Diabetes Association, 2004: 224-231.
4. Wolpert H. Smart Pumping for People with Diabetes. Alexandria, VA: American Diabetes Association, 2002.
5. Boland E, Monsod T, Delucia M, Brandt CA, Fernando S, Taborlane WV. Limitations of conventional methods of self-monitoring of blood glucose: Lessons learned from 3 days of continuous glucose sensing in pediatric patients with type 1 diabetes. Diabetes Care. 2001;24:1858-1862. (Pubitemid 33716491)
6. Kaufman FR, Gibson LC, Halvorson M, Carpenter S, Fisher LK, Pitukcheewanont P. A pilot study of the continuous glucose monitoring system: Clinical decisions and glycemic control after its use in pediatric type 1 diabetic subjects. Diabetes Care. 2001;24:2030-2034. (Pubitemid 33716516)
7. King AB, Armstrong DU. A prospective evaluation of insulin dosing recommendations in patients with type 1 diabetes at near normal glucose control: Basal dosing. J Diabetes Sci Technol. 2007;1:36-41.
8. King AB, Armstrong DU. A prospective evaluation of insulin dosing recommendations in patients with type 1 diabetes at near normal glucose control: Bolus dosing. J Diabetes Sci Technol. 2007;1:42-46.
9. King AB, Armstrong DU, Haller S, Gross TM, Fredrickson L. Continuous glucose monitoring provides a novel method for evaluating rule-based estimates of insulin sensitivity, 422-P. Diabetes. 2002;51(Suppl 1):A104.
10. King AB, Armstrong DU. A comparison of basal insulin delivery: Continuous subcutaneous insulin infusion versus glargine. Diabetes Care. 2003;26:1322. (Pubitemid 36929301)
11. King AB. Minimal reduction in insulin dosage with pramlintide therapy when pretreatment near-normal glycemia is established and square-wave meal bolus is used. Endocr Pract. 2009;15:229-233.